CUFinder

Andras Lacko

About Andras Lacko

Andras Lacko, With an exceptional h-index of 37 and a recent h-index of 19 (since 2020), a distinguished researcher at University of North Texas Health Science Center, specializes in the field of Drug Delivery, Lipoprotein metabolism.

His recent articles reflect a diverse array of research interests and contributions to the field:

A Spontaneous Assembling Lipopeptide Nanoconjugate Transporting the Anthracycline Drug N-Benzyladriamycin-14-valerate for Personalized Therapy of Ewing …

High-Density Lipoproteins and Cancer, with an Emphasis on Their Role in Immunotherapy

Prospects for developing lipoprotein-based drug transporters for therapeutic applications.

Receptor-mediated STING agonist delivery by mannose-decorated lipoprotein nanoparticles can repolarize ovarian cancer-educated macrophages

Developing a nanoparticle platform for selective delivery of the anti-cancer drug MIH 2.4 Bl to breast cancer cells

Mannose-functionalization of reconstituted high-density lipoprotein nanoparticles improves payload delivery and enhances M2-to-M1 phenotype reprogramming of RAW 264.7 …

Mannose-coated reconstituted lipoprotein nanoparticles for the targeting of tumor-associated macrophages: optimization, characterization, and in vitro evaluation of effectiveness

Pharmacological Modulation of B16‐F10 Murine Melanoma‐Induced TAMs Functional Phenotype via Lipoprotein‐Based Nanoparticles

Andras Lacko Information

University

Position

___

Citations(all)

4608

Citations(since 2020)

1344

Cited By

3816

hIndex(all)

37

hIndex(since 2020)

19

i10Index(all)

93

i10Index(since 2020)

30

Email

University Profile Page

Google Scholar

Andras Lacko Skills & Research Interests

Drug Delivery

Lipoprotein metabolism

Top articles of Andras Lacko

A Spontaneous Assembling Lipopeptide Nanoconjugate Transporting the Anthracycline Drug N-Benzyladriamycin-14-valerate for Personalized Therapy of Ewing …

Bioconjugate Chemistry

2024/2/6

Rafal Fudala
Rafal Fudala

H-Index: 15

High-Density Lipoproteins and Cancer, with an Emphasis on Their Role in Immunotherapy

2023/3/2

Rafal Fudala
Rafal Fudala

H-Index: 15

Prospects for developing lipoprotein-based drug transporters for therapeutic applications.

2023/1/31

Rong Ma
Rong Ma

H-Index: 6

Receptor-mediated STING agonist delivery by mannose-decorated lipoprotein nanoparticles can repolarize ovarian cancer-educated macrophages

Journal of Biological Chemistry

2023/1/1

Andras Lacko
Andras Lacko

H-Index: 19

Rafal Fudala
Rafal Fudala

H-Index: 15

Developing a nanoparticle platform for selective delivery of the anti-cancer drug MIH 2.4 Bl to breast cancer cells

2023

Dipti Debnath
Dipti Debnath

H-Index: 3

Mannose-functionalization of reconstituted high-density lipoprotein nanoparticles improves payload delivery and enhances M2-to-M1 phenotype reprogramming of RAW 264.7 …

Frontiers in Drug Delivery

2023/10/24

Rafal Fudala
Rafal Fudala

H-Index: 15

Mannose-coated reconstituted lipoprotein nanoparticles for the targeting of tumor-associated macrophages: optimization, characterization, and in vitro evaluation of effectiveness

Pharmaceutics

2023/6/8

Rafal Fudala
Rafal Fudala

H-Index: 15

Pharmacological Modulation of B16‐F10 Murine Melanoma‐Induced TAMs Functional Phenotype via Lipoprotein‐Based Nanoparticles

The FASEB Journal

2022/5

Andras Lacko
Andras Lacko

H-Index: 19

Rafal Fudala
Rafal Fudala

H-Index: 15

Novel HDL mimicking targeted drug delivery system for the treatment of Ewing Sarcoma

The FASEB Journal

2022/5

Andras Lacko
Andras Lacko

H-Index: 19

Rafal Fudala
Rafal Fudala

H-Index: 15

Reconstituted hdl nanoparticles for delivery of radioactive agents and uses thereof

2022/1/13

Targeted delivery of α-Mangostin to Prostate Cancer Cells Utilizing Reconstituted High-Density Lipoprotein Nanoparticles

2022

Andras Lacko
Andras Lacko

H-Index: 19

Rafal Fudala
Rafal Fudala

H-Index: 15

Reprogramming of B16-F10 melanoma-educated macrophages by STING agonists loaded in mannose-decorated reconstituted high density lipoprotein nanoparticles.

2022

Andras Lacko
Andras Lacko

H-Index: 19

Rafal Fudala
Rafal Fudala

H-Index: 15

An improved strategy for delivering the mesoionic compound MIH 2.4 Bl utilizing reconstituted high density nanoparticles (rHDL) in treating breast cancer

Cancer Research

2021/7/1

Dipti Debnath
Dipti Debnath

H-Index: 3

Rafal Fudala
Rafal Fudala

H-Index: 15

Mechanisms of chemoresistance and approaches to overcome its impact in gynecologic cancers

2021/1/1

Ezek Mathew
Ezek Mathew

H-Index: 2

Rafal Fudala
Rafal Fudala

H-Index: 15

Developing a stable drug delivery system for the mesoionic compound MIH 2.4 Bl using reconstituted high-density lipoproteins (rHDL) nanoparticles

2021

Dipti Debnath
Dipti Debnath

H-Index: 3

Andras Lacko
Andras Lacko

H-Index: 19

Rafal Fudala
Rafal Fudala

H-Index: 15

Optimization and characterization of mannose-decorated lipoprotein nanoparticles for the targeting of tumor-associated macrophages

2021

Rafal Fudala
Rafal Fudala

H-Index: 15

Andras Lacko
Andras Lacko

H-Index: 19

Fluorescence Characterization and Cellular Localization of the Mesoionic Compound MIH 2.4 Bl

2021

Dipti Debnath
Dipti Debnath

H-Index: 3

Andras Lacko
Andras Lacko

H-Index: 19

Rafal Fudala
Rafal Fudala

H-Index: 15

Characterization of rHDL Nanoparticles as a Delivery Vehicle for Glioblastoma Multiforme Chemotherapy

2021

Ezek Mathew
Ezek Mathew

H-Index: 2

Andras Lacko
Andras Lacko

H-Index: 19

Rafal Fudala
Rafal Fudala

H-Index: 15

Enhanced therapeutic agent and nucleic acid delivery via hdl or reconstituted hdl nanoparticles

2020/5/7

Characterization of DMXAA‐Loaded Reconstituted High‐Density Lipoprotein Nanoparticles

The FASEB Journal

2020/4

See List of Professors in Andras Lacko University(University of North Texas Health Science Center)